FDA Approves Trodelvy for Metastatic TNBC

Options
Moderators
Moderators Member Posts: 25,912
edited September 2020 in Triple-Negative Breast Cancer

Have you been diagnosed with metastatic triple-negative breast cancer that has stopped responding to at least two previous treatments? On April 22, 2020, the FDA granted accelerated approval to Trodelvy (chemical name: sacituzumab govitecan-hziy) to treat adults diagnosed with triple-negative disease.

Read the breaking news story here, and comment with your thoughts below.

Read more about Trodelvy (chemical name: sacituzumab govitecan-hziy).

· Share on FacebookShare on Twitter

Comments

  • anornurse
    anornurse Member Posts: 29
    edited September 2020

    I have been on trodelvy since 5/20. I have received 11 treatments with occasional diarrhea treated effectively with immodium and my white count has been normal to low normal. My cat scan after 8 treatments showed smaller lesions in both lungs. I will receive a cat scan in 5 more treatments. Trodelvy is my drug of choice!

    Sharon

    · Share on FacebookShare on Twitter

Categories